Эпидемиология ХОБЛ: современное состояние актуальной проблемы

1. World Health Organization Website. Chronic Obstructive Pulmonary Disease http://www.who.int/respiratory/copd

2. Stang P., Lydick E., Silberman C. et al. The prevalence of COPD: using smoking rates to estimate disease frequency in the general population. Chest 2000; 117 (suppl. 2): 354S–59S.

3. Sobradillo2Pena V., Miravitlles M., Gabriel R. et al. Geographic variations in prevalence and underdiagnosis of COPD: results of the IBERPOC multicentre epidemiological study. Chest 2000; 118: 981–989.

4. Halbert R.J., Natoli J.L., Gano A. et al. Global burden of COPD: systematic review and meta-analysis. Eur. Respir. J. 2006; 28: 523–532.

5. Vandevoorde J., Verbanck S., Gijssels L. et al. Early detection of COPD: A case finding study in general practice. Respir. Med. 2007; 101 (3): 525–530.

6. von Hertzen L., Reunanen A., Impivaara O. et al. Airway obstruction in relation to symptoms in chronic respiratory disease: a nationally representative population study. Respir. Med. 2007; 94: 356–363.

7. Executive summary: Global strategy for the diagnosis, management, and prevention of COPD. http://www.goldcopd.com

8. Halbert R.J., Isonaka S., George D. et al. Interpreting COPD Prevalence estimates: What is the true burden of disease? Chest 2003; 123: 1684–1692.

9. BTS guidelines for the management of chronic obstructive pulmonary disease. Thorax 1997; 52: 1–28.

10. Siafakas N.M., Vermeire P., Pride N.B. Optimal assessment and management of chronic obstructive pulmonary disease (COPD). Eur. Respir. J. 1995; 8: 1398–1420.

11. American Thoracic Society. Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am. Rev. Respir. Dis. 1987; 136: 225–44.

12. Van Schayck C.P. Diagnosis of asthma and chronic obstructive pulmonary disease in general practice. Br. J. Gen. Pract. 1996, 46: 193–197.

13. Mueller R.E., Keble D.L., Plummer J. et al. The prevalence of chronic bronchitis, chronic airway obstruction, and respiratory symptoms in a Colorado city. Am. Rev. Respir. Dis. 1971; 103: 209–228.

14. Murray C.J.L., Lopez A.D., eds. The global burden of disease: a comprehensive assessment of mortality and disability from diseases, injuries and risk factors in 1990 and projected to 2020. Cambridge, MA: Harvard University Press; 1996.

15. National Center for Health Statistics. Current estimates from the National Health Interview Survey, United States, 1995. Washington, DC: Department of Health and Human Services, Public Health Service, Vital and Health Statistics; 1995. Publ. 96–1527.

16. Lange P., Groth S., Nyboe J. et al. Chronic obstructive lung disease in Copenhagen: cross-sectional epidemiological aspects. J. Intern. Med. 1989; 226: 25–32.

17. ATS/ERS task force: standardisation of lung function testing. Standardisation of spirometry. Eur. Respir. J. 2005; 26: 319–338.

18. PLATINO project website http://www.platino-alat.org

19. Menezes A.B., Perez-Padilla R., Jardim J.R. et al. Chronic obstructive pulmonary disease in five Latin American cities (the PLATINO study): a prevalence study. Lancet 2005; 366: 1875–1881.

20. BOLD project website http://www.kpchr.org/boldcopd

21. Schirnhofer L., Lamprecht B., Vollmer W. et al. COPD prevalence in Slazburg Austria: Results from the Burden of Lung Disease Study (BOLD). Chest 2007; 131: 29–36.

22. Визель А.А., Гильманов А.А., Пронина И.Ю. и др. Хроническая обструктивная болезнь легких: особенности эпидемиологии и фармакоэпидемиологии в Республике Татарстан. Consilium Medicum 2007; 3: 66–70.

23. Войнов А.И., Лобанов А.А. Эпидемиология хронических обструктивных заболеваний легких. Медицина труда и пром. экология 2003; 4: 23–25.

24. Чучалин А.Г. (ред.). Хроническая обструктивная болезнь легких. Федеральная программа. М.; 2004.